• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine.

作者信息

Liu-Chen L Y, Phillips C A

机构信息

Central Research and Development Department, E.I. Du Pont De Nemours and Co., Wilmington, Delaware 19898.

出版信息

Mol Pharmacol. 1987 Sep;32(3):321-9.

PMID:2823089
Abstract

[3H]beta-funaltrexamine ([3H]beta-FNA) bound irreversibly to bovine striatal membranes. Naloxone inhibited the irreversible binding of 5 nM [3H]beta-FNA in a dose-dependent manner and maximally inhibited this binding at approximately 1 microM. Thus, the specific irreversible binding of [3H]beta-FNA to opioid receptors was defined as that which could be inhibited by 1 microM naloxone. This specific irreversible binding of [3H]beta-FNA was characterized. Exclusion of Na+ from the incubation medium reduced the specific binding of [3H]beta-FNA, and Na+ could be substituted by Li+ but not by K+, Cs+, Mg2+, or guanylylimidodiphosphate. The specific irreversible binding was saturable, time- and temperature-dependent, and was linearly related to tissue mass. Several drugs were used to characterize this specific binding. Levorphanol was 1000 times more potent as an inhibitor than dextrorphan. mu Opioid ligands (sufentanil and morphine) were much better inhibitors than delta (ICI174,864) or kappa (U50,488H) ligands. The potency of [D-Ala2, D-Leu5]enkephalin (DADLE) was between those of sufentanil and ICI174,864. These results demonstrated that under appropriate conditions [3H]beta-FNA specifically and irreversibly bound to the mu opioid binding site. Membrane preparations labeled with [3H]beta-FNA in the presence or absence of 1 microM naloxone or beta-FNA were subjected to polyacrylamide gel electrophoresis under denaturing and reducing conditions. Fluorograms showed that [3H]beta-FNA specifically bound to a protein (most likely the mu opioid binding site) that migrated as a band with a molecular weight range of 68,000-97,000. Such electrophoretic behavior indicates that it is likely to be a glycoprotein. The glycoprotein nature was confirmed by its adsorption onto a wheat germ lectin-Sepharose column after solubilization and subsequent elution by N-acetyl-D-glucosamine. In this lectin column eluate, the mu opioid receptor was the only protein band labeled by [3H]beta-FNA in the total binding preparation, and no labeled protein was observed in the nonspecific binding preparation. When the wheat germ lectin column eluate of the total binding was treated with peptide:N-glycosidase F, the broad labeled band of Mr 68,000-97,000 became a sharp band of Mr 57,000 with high radioactivity and a faintly labeled band of Mr 49,000.

摘要

相似文献

1
Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine.
Mol Pharmacol. 1987 Sep;32(3):321-9.
2
Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.β-[³H]氟纳曲胺标记的μ阿片受体:分子量及复杂型N-连接寡糖糖基化的种属差异
Mol Pharmacol. 1993 Oct;44(4):749-56.
3
Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
Mol Pharmacol. 1990 Feb;37(2):243-50.
4
Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.β-芬太尼酰去甲丙胺与大鼠脑内[³H]环FOXY结合的相互作用:β-FNA使阿片受体复合物烷基化的进一步证据。
Synapse. 1991 Jun;8(2):86-99. doi: 10.1002/syn.890080203.
5
Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.β-芬太尼环丙基甲基酮在豚鼠脑膜中与μ、δ和κ阿片受体的可逆和不可逆结合。
J Pharmacol Exp Ther. 1986 Nov;239(2):351-7.
6
Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.脑室内注射β-芬太尼环唑对大鼠脑内μ阿片受体的影响:结合条件的考量
J Pharmacol Exp Ther. 1995 Jun;273(3):1047-56.
7
Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).非平衡型μ拮抗剂β-芬太尼酰基去甲丙胺(β-FNA)的阿片受体结合特性
Eur J Pharmacol. 1985 Jan 8;107(3):323-30. doi: 10.1016/0014-2999(85)90257-2.
8
beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
J Pharmacol Exp Ther. 1988 Nov;247(2):405-16.
9
Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.人[125I]β-内啡肽与大鼠纹状体膜中阿片受体的交联:μ/δ阿片受体复合物存在的生化证据。
J Pharmacol Exp Ther. 1990 Apr;253(1):419-26.
10
Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptor.
J Biol Chem. 1995 Jul 28;270(30):17866-70. doi: 10.1074/jbc.270.30.17866.

引用本文的文献

1
Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox.新型配体甲氧基肉桂诺对 μ 阿片受体的长期拮抗和变构调节。
Pharmacol Res Perspect. 2021 Dec;9(6):e00887. doi: 10.1002/prp2.887.
2
Effects of defeat stress on behavioral flexibility in males and females: modulation by the mu-opioid receptor.失败应激对雄性和雌性行为灵活性的影响:μ-阿片受体的调节作用。
Eur J Neurosci. 2015 Feb;41(4):434-41. doi: 10.1111/ejn.12824. Epub 2015 Jan 23.
3
Mu opioids and their receptors: evolution of a concept.
μ 阿片类药物及其受体:概念的演变。
Pharmacol Rev. 2013 Sep 27;65(4):1257-317. doi: 10.1124/pr.112.007138. Print 2013.
4
Detection of the endogenous mu opioid receptor (mopr) in brain.大脑中内源性μ阿片受体(mopr)的检测。
Front Biosci (Elite Ed). 2009 Jun 1;1(1):220-7. doi: 10.2741/E21.
5
Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.μ-反义寡脱氧核苷酸在体内作为μ阿片受体非竞争性拮抗剂的应用。
Neurochem Res. 1996 Nov;21(11):1363-8. doi: 10.1007/BF02532377.